These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9563829

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relation between reticulocyte count and characteristics of erythrocyte 5'-nucleotidase in dogs, cats, cattle and humans.
    Hossain MA, Yamato O, Yamasaki M, Otsuka Y, Maede Y.
    J Vet Med Sci; 2003 Feb; 65(2):193-7. PubMed ID: 12655113
    [Abstract] [Full Text] [Related]

  • 6. Deficiency of pyrimidine 5'-nucleotidase in human leukocytes.
    de Korte D, van Doorn CC, Sijstermans JM, van Gennip AH, Roos D.
    J Inherit Metab Dis; 1989 Feb; 12(3):267-72. PubMed ID: 2559246
    [Abstract] [Full Text] [Related]

  • 7. Erythrocyte pyrimidine 5'-nucleotidase inhibition by acute lead exposure in neonatal rats.
    Konantakieti C, Beuthin FC, Louis-Ferdinand RT.
    J Biochem Toxicol; 1986 Sep; 1(3):51-9. PubMed ID: 2856073
    [Abstract] [Full Text] [Related]

  • 8. Isozymes of human erythrocyte pyrimidine 5'-nucleotidase--chromatographic separation and their properties.
    Hirono A, Fujii H, Miwa S.
    Jpn J Exp Med; 1985 Feb; 55(1):37-44. PubMed ID: 2993713
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pyrimidine nucleoside monophosphate kinase hyperactivity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA, Zerez CR, Tanaka KR.
    Br J Haematol; 1987 May; 66(1):91-6. PubMed ID: 3036196
    [Abstract] [Full Text] [Related]

  • 11. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA, Zerez CR, Tanaka KR.
    Biochim Biophys Acta; 1989 Jan 19; 994(1):81-8. PubMed ID: 2535789
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of lead exposure in workers at a lead-acid battery factory in Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Kim Y, Harada K, Ohmori S, Lee BK, Miura H, Ueda A.
    Occup Environ Med; 1995 Jul 19; 52(7):484-8. PubMed ID: 7670624
    [Abstract] [Full Text] [Related]

  • 13. Erythrocyte pyrimidine 5'-nucleotidase and deoxynucleotidase isozymes: metallosensitivity and kinetics.
    Cook L, Kubitschek C, Stohs S, Angle C.
    Drug Chem Toxicol; 1988 Jun 19; 11(2):195-213. PubMed ID: 2841083
    [Abstract] [Full Text] [Related]

  • 14. Studies on erythrocyte pyrimidine 5'-nucleotidase (P5N) test and its evaluation in workers occupationally exposed to lead.
    Ichiba M, Tomokuni K.
    Int Arch Occup Environ Health; 1990 Jun 19; 62(4):305-10. PubMed ID: 2379961
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Electrophoretic and kinetic studies of a mutant red cell pyrimidine 5'-nucleotidase.
    Fujii H, Nakashima K, Miwa S, Nomura K.
    Clin Chim Acta; 1979 Jul 02; 95(1):89-92. PubMed ID: 509733
    [Abstract] [Full Text] [Related]

  • 17. Erythrocyte arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N) as indices of lead exposure.
    Cook LR, Angle CR, Stohs SJ.
    Br J Ind Med; 1986 Jun 02; 43(6):387-90. PubMed ID: 3013277
    [Abstract] [Full Text] [Related]

  • 18. Pyrimidine 5'-nucleotidase deficiency: improved detection of carriers.
    de Korte D, Sijstermans JM, Seip M, van Doorn CC, van Gennip AH, Roos D.
    Clin Chim Acta; 1989 Sep 29; 184(2):175-80. PubMed ID: 2557985
    [Abstract] [Full Text] [Related]

  • 19. Erythrocyte nucleotides in lead workers.
    Ichiba M, Tomokuni K, Mori K.
    Int Arch Occup Environ Health; 1992 Sep 29; 63(6):419-21. PubMed ID: 1544691
    [Abstract] [Full Text] [Related]

  • 20. Structure of pyrimidine 5'-nucleotidase type 1. Insight into mechanism of action and inhibition during lead poisoning.
    Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips GN.
    J Biol Chem; 2006 Jul 21; 281(29):20521-9. PubMed ID: 16672222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.